Evidence map›Paper›PMID 24978480›Full record

ArticlePloS one2014

A colorectal cancer susceptibility new variant at 4q26 in the Spanish population identified by genome-wide association analysis.

Luis M Real, Agustín Ruiz, Javier Gayán, Antonio González-Pérez, María E Sáez, Reposo Ramírez-Lorca, Francisco J Morón, Juan Velasco, Ruth Marginet-Flinch, Eva Musulén and 15 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  6. Interaction of CCND2, CDKN1A, and POLD3 Variants in Mexican Patients with Colorectal Cancer.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 2 countries.

Luis M RealDepartment of Structural Genomics, Neocodex, Seville, Spain; Infectious Diseases and Microbiology Unit, Hospital Nuestra Señora de Valme, Seville, Spain; Institute of Biomedicine of Seville (IBIS), Seville, Spain.
Agustín RuizDepartment of Structural Genomics, Neocodex, Seville, Spain; Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
Javier GayánDepartment of Structural Genomics, Neocodex, Seville, Spain; Bioinfosol, Seville, Spain.
Antonio González-PérezDepartment of Structural Genomics, Neocodex, Seville, Spain; Andalusian Center for Bioinformatic Studies (CAEBI), Seville, Spain.
María E SáezDepartment of Structural Genomics, Neocodex, Seville, Spain; Andalusian Center for Bioinformatic Studies (CAEBI), Seville, Spain.
Reposo Ramírez-LorcaDepartment of Structural Genomics, Neocodex, Seville, Spain; Institute of Biomedicine of Seville (IBIS), Seville, Spain.
Francisco J MorónDepartment of Structural Genomics, Neocodex, Seville, Spain; Institute of Biomedicine of Seville (IBIS), Seville, Spain.
Juan VelascoDepartment of Structural Genomics, Neocodex, Seville, Spain; Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Barcelona, Spain.
Ruth Marginet-FlinchDepartment of Structural Genomics, Neocodex, Seville, Spain; Department of Pathology, Hospital Universitario Germans Trias i Pujol (HUGTP), Badalona, Barcelona, Spain.
Eva MusulénDepartment of Pathology, Hospital Universitario Germans Trias i Pujol (HUGTP), Badalona, Barcelona, Spain.
José M CarrascoDepartment of Structural Genomics, Neocodex, Seville, Spain.
Concha Moreno-ReyDepartment of Structural Genomics, Neocodex, Seville, Spain; Department of Oncology, Hospital Virgen del Rocío, Seville, Spain.
Enrique VázquezDepartment of Structural Genomics, Neocodex, Seville, Spain.
Manuel Chaves-CondeDepartment of Oncology, Hospital Virgen del Rocío, Seville, Spain.
Jose A Moreno-NogueiraDepartment of Oncology, Hospital Virgen del Rocío, Seville, Spain.
Manuel Hidalgo-PascualColorectal Surgery Unit, Hospital 12 de Octubre, Madrid, Spain.
Eduardo Ferrero-HerreroColorectal Surgery Unit, Hospital 12 de Octubre, Madrid, Spain.
Sergi Castellví-BelDepartment of Gastroenterology, Hospital Clínic, University of Barcelona, CIBEREHD, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Antoni CastellsDepartment of Gastroenterology, Hospital Clínic, University of Barcelona, CIBEREHD, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Ceres Fernandez-RozadillaGalician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Red de Enfermedades Raras, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, A Coruña, Spain.
Clara Ruiz-PonteGalician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Red de Enfermedades Raras, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, A Coruña, Spain.
Angel CarracedoGalician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Red de Enfermedades Raras, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, A Coruña, Spain.
Beatriz GonzálezInstitute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Barcelona, Spain.
Sergio AlonsoInstitute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Barcelona, Spain.
Manuel PeruchoInstitute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Barcelona, Spain; Sanford-Burnham Medical Research Institute (SBMRI), La Jolla, California United States of America; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Institute of Predictive and Personalized Medicine of Cancer · ESCentro de Investigación Biomédica en Red · ESHospital Universitario Virgen del Rocío · ESCentro Andaluz de Biología del Desarrollo · ESHospital Universitari Germans Trias i Pujol · ESInstituto de Biomedicina de Sevilla · ESResearch Institute Hospital 12 de Octubre · ESCentre for Biomedical Network Research on Rare Diseases · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESFundació ACE · ESHospital Universitario de Valme · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-hereditary colorectal cancer (CRC) is a complex disorder resulting from the combination of genetic and non-genetic factors. Genome-wide association studies (GWAS) are useful for identifying such genetic susceptibility factors. However, the single loci so far associated with CRC only represent a fraction of the genetic risk for CRC development in the general population. Therefore, many other genetic risk variants alone and in combination must still remain to be discovered. The aim of this work was to search for genetic risk factors for CRC, by performing single-locus and two-locus GWAS in the Spanish population.

resultsA total of 801 controls and 500 CRC cases were included in the discovery GWAS dataset. 77 single nucleotide polymorphisms (SNP)s from single-locus and 243 SNPs from two-locus association analyses were selected for replication in 423 additional CRC cases and 1382 controls. In the meta-analysis, one SNP, rs3987 at 4q26, reached GWAS significant p-value (p = 4.02×10(-8)), and one SNP pair, rs1100508 CG and rs8111948 AA, showed a trend for two-locus association (p = 4.35×10(-11)). Additionally, our GWAS confirmed the previously reported association with CRC of five SNPs located at 3q36.2 (rs10936599), 8q24 (rs10505477), 8q24.21(rs6983267), 11q13.4 (rs3824999) and 14q22.2 (rs4444235).

conclusionsOur GWAS for CRC patients from Spain confirmed some previously reported associations for CRC and yielded a novel candidate risk SNP, located at 4q26. Epistasis analyses also yielded several novel candidate susceptibility pairs that need to be validated in independent analyses.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyChromosomes, Human, Pair 4Colorectal NeoplasmsDatabases, GeneticHumansMeta-Analysis as TopicPolymorphism, Single NucleotideReproducibility of ResultsSpain

Identifiers

PMID24978480
PMCPMC4076321
OpenAlexW1975753346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.